Skip to main content
. 2015 Summer;14(3):677–691.

Figure 5.

Figure 5

Comparative in-vivo peak plasma concentration of starch (F1), acetylated starch (F2) matrix tablets, graft copolymer matrix tablets (F3 and F4), HPMC K100M matrix tablets (F5) and Asthalin SA.